Mycobacterium tuberculosis inducing disseminated intravascular coagulation

Summary

Disseminated intravascular coagulation (DIC) can develop infrequently in patients with tuberculosis and has a very high mortality rate. We conducted a retrospective study to evaluate the incidence of tuberculosis-induced DIC and to investigate the clinical manifestation, outcome, and prognostic factors of such patients. From January 2002 to December 2003, all culture-proven tuberculosis patients who developed DIC before starting anti-tuberculosis treatments were selected for this study. Patients who had other clinical conditions or were infected by other pathogens that may have been responsible for their DIC were excluded. Survival analysis was performed for each variable with possible prognostic significance. Our results showed that 27 (3.2%) out of the 833 patients with culture-proven tuberculosis had tuberculosis-induced DIC with a mortality rate of 63.0%. The most common clinical manifestations were fever (63.0%) and multiple patches of pulmonary consolidation (59.3%). Seven (25.9%) patients had disseminated tuberculosis. Twelve (44.4%) developed acute respiratory distress syndrome and three (11.1%) were associated with hemophagocytosis. Twenty-four (88.9%) patients had findings that were unusual for an acute bacterial infection, such as positive acid-fast smear, miliary pulmonary lesions, lymphocytotic exudative pleural effusion, and mediastinal lymphadenopathy. Early anti-tuberculosis treatment significantly improved survival. In conclusion, tuberculosis can cause DIC. Patients with non-miliary, non-disseminated tuberculosis could also develop the rare clinical manifestation. Since the prognosis was very poor in patients not treated at an early stage, a high index of suspicion is required, especially in those with clinical findings suggestive of tuberculosis.

Keywords

Tuberculosis - disseminated intravascular coagulation - acute respiratory distress syndrome - hemophagocytosis - early treatment

• References

• 1 World Health Organization. Group at risk: WHO report on the tuberculosis epidemic. Geneva, Switzerland: World Health Organization; 1996
• 2 Bureau for Chronic Disease Control. Tuberculosis annual report (Taiwan) 2001. Taipei, Taiwan: Bureau for Chronic Disease Control; 2002
• 3 Glasser RM, Walker I R, Herion JC. The significance of hematologic abnormalities in patients with tuberculosis. Arch Intern Med 1970; 125: 691-5.
• 4 Yu YL, Chow WH, Humphries MJ. et al. Cryptic miliary tuberculosis. Q J Med 1986; 59: 421-8.
• 5 Munt PW. Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults. Medicine (Baltimore) 1972; 51: 139-55.
• 6 Mavligit GM, Binder RA, Crosby WH. Disseminated intravascular coagulation in miliary tuberculosis. Arch Intern Med 1972; 130: 388-9.
• 7 Rosenberg MJ, Rumans LW. Survival of a patient with pancytopenia and disseminated coagulation associated with miliary tuberculosis. Chest 1978; 73: 536-9.
• 8 Nampoory MR, Halim MM, Sreedharan R. et al. Liver abscess and disseminated intravascular coagulation in tuberculosis. Postgrad Med J 1995; 71: 490-2.
• 9 Manzella JP, Kellogg J, Sanstead JK. Mycobacterium tuberculosis bacteremia and disseminated coagulation. Jama 1985; 254: 2741
• 10 Godwin JE, Coleman AA, Sahn SA. Miliary tuberculosis presenting as hepatic and renal failure. Chest 1991; 99: 752-4.
• 11 Nolte FS, Metchock B. Mycobacterium. 6th ed Washington, DC: American Society for Microbiology; 1995
• 12 National Committee for Clinical Laboratory Standards (NCCLS) Antimycobacterial susceptibility testing for Mycobacterium tuberculosis: tentative standard. NCCLS document 1995; M24-T
• 13 O'Sullivan CE, Miller DR, Schneider PS. et al. Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory. J Clin Microbiol 2002; 40: 1723-7.
• 14 Crump JA, Reller LB. Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture. Clin Infect Dis 2003; 37: 1037-43.
• 15 Bernard GR, Artigas A, Brigham KL. et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
• 16 Taylor , Jr. FB, Toh CH, Hoots WK. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
• 17 Christensen E, Schlichting P, Fauerholdt L. et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4: 430-5.
• 18 Goldfine ID, Schachter H, Barclay WR. et al. Consumption coagulopathy in miliary tuberculosis. Ann Intern Med 1969; 71: 775-7.
• 19 Krauss JS, Walker DH. Miliary tuberculosis and consumption of clotting factors by multifocal vasculopathic coagulation. South Med J 1979; 72: 1479-81.
• 20 Sarma PS, Viswanathan KA, Budhiraja A. et al. Pancytopenia and D.I.C. in disseminated tuberculosis. J Assoc Physicians India 1984; 32: 601-2.
• 21 Stein DS, Libertin CR. Disseminated intravascular coagulation in association with cavitary tuberculosis. South Med J 1990; 83: 60-3.
• 22 Fujita M, Kunitake R, Nagano Y. et al. Disseminated intravascular coagulation associated with pulmonary tuberculosis. Intern Med 1997; 36: 218-20.
• 23 Zhang J, Handorf C. Miliary tuberculosis presenting as acute respiratory distress syndrome, septic shock, DIC, and multiorgan failure. Tenn Med 2004; 97: 164-6.
• 24 Pasculle AW, Kapadia SB, Ho M. Tuberculous bacillemia, hyperpyrexia, and rapid death. Arch Intern Med 1980; 140: 426-7.
• 25 Eliopoulos G, Vaiopoulos G, Kittas C. et al. Tuberculosis associated hemophagocytic syndrome complicated with severe bone marrow failure and disseminated intravascular coagulation. Nouv Rev Fr Hematol 1992; 34: 273-6.
• 26 Baumann WR, Jung RC, Koss M. et al. Incidence and mortality of adult respiratory distress syndrome: a prospective analysis from a large metropolitan hospital. Crit Care Med 1986; 14: 1-4.
• 27 Round table conference Acute lung injury. Am J Respir Crit Care Med 1998; 158: 675-9.
• 28 Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-49.
• 29 Case records of the Massachusetts General Hospital Weekly clinicopathological exercises. Case 23–1995. A 44-year-old woman with pulmonary infiltrates, respiratory failure, and pancytopenia. N Engl J Med 1995; 333: 241-8.
• 30 Mofredj A, Guerin JM, Leibinger F. et al. Adult respiratory distress syndrome and pancytopenia associated with miliary tuberculosis in a HIV-infected patient. Eur Respir J 1996; 9: 2685-7.
• 31 Kim JY, Park YB, Kim YS. et al. Miliary tuberculosis and acute respiratory distress syndrome. Int J Tuberc Lung Dis 2003; 7: 359-64.
• 32 Pavlatos S, Psallas M, Makrilakis K. et al. Acute respiratory distress syndrome due to miliary tuberculosis in a patient with rheumatoid arthritis under corticosteroid therapy. Eur J Intern Med 2004; 15: 62-4.
• 33 Shin BC, Kim SW, Ha SW. et al. Hemophagocytic syndrome associated with bilateral adrenal gland tuberculosis. Korean J Intern Med 2004; 19: 70-3.
• 34 Chien CC, Chiou TJ, Lee MY. et al. Tuberculosisassociated hemophagocytic syndrome in a hemodialysis patient with protracted fever. Int J Hematol 2004; 79: 334-6.
• 35 Modi C, Dhamne A, Rege JD. Haemophagocytosis in tuberculosis--a case report. Indian J Pathol Microbiol 2003; 46: 463-5.
• 36 Dilber E, Erduran E, Kalyoncu M. et al. Hemophagocytic syndrome as an initial presentation of miliary tuberculosis without pulmonary findings. Scand J Infect Dis 2002; 34: 689-92.
• 37 Goto S, Aoike I, Shibasaki Y. et al. A successfully treated case of disseminated tuberculosis-associated hemophagocytic syndrome and multiple organ dysfunction syndrome. Am J Kidney Dis 2001; 38: E19
• 38 Yang CW, Lee JH, Kim YG. et al. Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient: case report and review of the literature. Nephron 1996; 72: 690-2.
• 39 Cassim KM, Gathiram V, Jogessar VB. Pancytopaenia associated with disseminated tuberculosis, reactive histiocytic haemophagocytic syndrome and tuberculous hypersplenism. Tuber Lung Dis 1993; 74: 208-10.
• 40 Monier B, Fauroux B, Chevalier JY. et al. Miliary tuberculosis with acute respiratory failure and histiocytic hemophagocytosis. Successful treatment with extracorporeal lung support and epipodophyllotoxin VP 16–213. Acta Paediatr 1992; 81: 725-7.
• 41 Campo E, Condom E, Miro MJ. et al. Tuberculosisassociated hemophagocytic syndrome. A systemic process. Cancer 1986; 58: 2640-5.
• 42 Weintraub M, Siegman-Igra Y, Josiphov J. et al. Histiocytic hemophagocytosis in miliary tuberculosis. Arch Intern Med 1984; 144: 2055-6.
• 43 Barnes N, Bellamy D, Ireland R. et al. Pulmonary tuberculosis complicated by haemophagocytic syndrome and rifampicin-induced tubulointerstitial nephritis. Br J Dis Chest 1984; 78: 395-403.
• 44 Narain R, Gothi GD, Nair SS. Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ 1974; 51: 473-88.
• 45 Diagnostic Standards and Classification of Tuberculosis in Adults and Children This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161: 1376.-95.
• 46 FitzGerald R, Hutchinson CE. Tuberculosis of the ribs: computed tomographic findings. Br J Radiol 1992; 65: 822-824.
• 47 Wang JY, Lee LN, Hsueh PR. et al. Tuberculous myositis: a rare but existing clinical entity. Rheumatology (Oxford) 2003; 42: 836-40.
• 48 Andrew OT, Schoenfeld PY, Hopewell PC. et al. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: 59-65.
• 49 Wallis RS, Ellner JJ. Cytokines and tuberculosis. J Leukoc Biol 1994; 55: 676-81.